Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) active compounds. It exhibits potential in the formulation of anxiolytic and sedative drugs due to its structural affinity with GABA receptor modulators. Also employed in research settings for structure-activity relationship (SAR) studies of quinazoline-based bioactive molecules. Its derivatives are explored for anti-inflammatory and anticonvulsant properties. Commonly utilized in medicinal chemistry for optimizing drug candidates targeting neurological disorders.